UNIGE document Doctoral Thesis
previous document  unige:18457  next document
add to browser collection
Title

Population pharmacokinetics and pharmacogenetics of antiretroviral drugs

Author
Director
Defense Thèse de doctorat : Univ. Genève, 2012 - Sc. 4400 - 2012/01/13
Abstract The population pharmacokinetic approach has proved its usefulness for Therapeutic Drug Monitoring (TDM) and it allows in particular, the quantification of pharmacokinetic variability, and offers the possibility to detect clinically useful predictors of treatment outcomes. In that perspective, we performed a first pharmacogenetic-based population pharmacokinetic analysis of efavirenz in HIV infected individuals. We demonstrated that functional alleles of CYP2B6 were associated with higher Efavirenz exposure. We proposed an innovative non-linear model to describe the relationship between phenotypes and functional allelic variants and accordingly predict Efavirenz exposure. We developed Pop-PK models for darunavir, etravirine and raltegravir. We identified demographic and environmental factors affecting drug disposition. We simulated compare drug exposure under several dosage regimens. Finally, we derived reference pharmacokinetic curves for 7 widely used antiretroviral drugs based on an innovative concept of meta-analysis that could represent useful tools for clinicians to interpret the value of an individual plasma concentration whenever needed.
Keywords HIVPopulation PharmacokineticsPharmacogeneticsNONMEMTDM
Identifiers
URN: urn:nbn:ch:unige-184576
Full text
Thesis (3.5 MB) - public document Free access
Structures
Citation
(ISO format)
ARAB, Mona. Population pharmacokinetics and pharmacogenetics of antiretroviral drugs. Université de Genève. Thèse, 2012. https://archive-ouverte.unige.ch/unige:18457

299 hits

1139 downloads

Update

Deposited on : 2012-02-21

Export document
Format :
Citation style :